Form D · Biotechnology

GeneTx Biotherapeutics LLC

Downers Grove, IL · CIK 0001757906

Offering snapshot reported Apr 3, 2019 · SEC filing

Reported sold
$6.32M
Offering amount: $6.32M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 19, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.16M$6.32MNov 2, 2018: $3,824,160.00Nov 2, 2018Apr 3, 2019: $6,324,132.00Apr 3, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,824,160 → $6,324,132
  • Reported investors6 → 7

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 3, 2019Amendment$6,324,132$2,499,972vs Nov 2, 20187SEC filing
Nov 2, 2018Initial$3,824,160No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-325016

Source: Form D, filed Apr 3, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Allyson Berent Director, Executive
Paula Evans Director, Executive
Michael Hanrahan Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1202 N 75th Street #247
Downers Grove, IL, 60516